Project Grant HT94252310112
Award Date
4/1/23
Completion Date
3/31/25
Dollars Obligated
$155K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
The University of Maryland, Baltimore was awarded a $1.15 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on BPTF-Mediated Gene Regulation in Prostate Cancer from August 1, 2022 to July 31, 2025. As part of the Military Medical Research and Development program's goal of transforming health care for service members and the public through innovative biomedical research, this project aims...
The University of Maryland, Baltimore will conduct research on the regulation of cellular plasticity by androgen receptor splicing variants in prostate cancer under a three-year, $1,390,500 Project Grant from the Defense Health Agency. The grant supports the Military Medical Research and Development program, which aims to transform military and public health through innovative medical research solutions for battlefield wounds and illnesses. The University will investigate medical solutions for...
The University of Maryland, Baltimore (UMB) was awarded a $587,271 Project Grant from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), to conduct research on "DUAL INHIBITION OF PARP AND IL-6 AS A NOVEL THERAPEUTIC APPROACH FOR BRCA-MUTATED TRIPLE-NEGATIVE BREAST CANCER." This research project will occur from July 1, 2024 to June 30, 2027. The Military Medical Research and Development program supports a...
The University of Maryland, College Park will receive $712,011 through a three-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support modeling and cross-sectional analysis of movement quality for service members using osseointegrated prostheses. Through June 2026, the University will conduct research to transform health care and investigate medical solutions for the battlefield....
The University of Alabama at Birmingham (UAB) was awarded a $220,326 Project Grant under the Department of the Army's Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from April 1, 2025 to March 31, 2027, supports the development of novel, selective PARP protein degraders for prostate cancer treatment utilizing PSMA uptake enhancement. This research aims to transform healthcare for military service members and the broader public by advancing...
The University of Maryland, Baltimore will conduct research on the clinical utility of microfluidic assays for prognosis and precision medicine in breast cancer under a $958,563 project grant from the Defense Health Agency. The grant falls under the Military Medical Research and Development program, which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and investigations into medical issues. The three-year...
The University of Maryland, College Park was awarded a $349,778 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund an evaluation of mechanical loads on an osseointegrated implant during locomotor activities of daily living from May 2021 through May 2024. Through this funding, University of Maryland researchers will investigate how mechanical forces impact bone-implanted prosthetics during...
This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
The University of Maryland Baltimore County (UMBC) was awarded a $1,064,564 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds UMBC research from June 2023 to June 2027 on the role and regulation of ZNF217 in ovarian cancer metastasis and drug resistance. As the prime awardee, UMBC will conduct research to investigate medical solutions for ovarian cancer on the battlefield and transform healthcare for service...
The University of Maryland, Baltimore (UMB) was awarded a $1,383,874 Project Grant under the U.S. Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on March 1, 2025, supports a 4-year research project titled "Deciphering the Tripartite Intramolecular Regulatory Mechanism of Polycystin 1 Implicated in Polycystic Kidney Disease." This research aims to advance the understanding of the molecular...